31Indexed trials
mesh condition
Glioblastoma
Intelligence
Glioblastoma intelligence: 31 indexed trials, 7 recruiting studies, 28 sponsors across 28 countries.
7Recruiting
28Sponsors
28Countries
Leading sponsors
Cortice Biosciences, Inc.20 recruiting
Annick Desjardins20 recruiting
Assistance Publique - Hôpitaux de Paris21 recruiting
Duke University10 recruiting
Insel Gruppe AG, University Hospital Bern11 recruiting
Erasmus Medical Center10 recruiting
Hoffmann-La Roche10 recruiting
German Cancer Research Center11 recruiting
European Organisation for Research and Treatment of Cancer - EORTC10 recruiting
INSYS Therapeutics Inc10 recruiting
DelMar Pharmaceuticals, Inc.10 recruiting
Beijing Neurosurgical Institute10 recruiting
Geographic activity
United States16trials
Germany10trials
Switzerland7trials
Netherlands6trials
France5trials
Belgium4trials
Austria4trials
United Kingdom4trials
Canada3trials
Spain3trials
Israel2trials
Denmark2trials
Leading interventions
Bevacizumab3trials
Temozolomide3trials
TPI 2872trials
APG1011trials
Alectinib1trials
Asleep mapping under general anesthesia1trials
Adjuvant chemotherapy as normal based on standard clinical protocols determined by the neuro-oncologist1trials
Awake craniotomy1trials
Awake mapping under local anesthesia1trials
Atezolizumab1trials
Cerebral open flow microperfusion1trials
AZD74511trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.